Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04896658
Title Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Maryland, Baltimore
Indications

multiple myeloma

Therapies

belantamab mafodotin-blmf + Cyclophosphamide + Dexamethasone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.